Keywords: Merck & Co, Nosonex, Patent ruling, USA, Apotex, Allergy drug

Mixed US court ruling on Merck & Co's Nasonex patent

Article | 19 June 2012

Print This

The US District Court for the District of New Jersey has ruled against US drug giant Merck & Co (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in